search
Back to results

Quality of Life of Caregivers and Patients Suffering From Multiple System Atrophy (QUA2-AMS)

Primary Purpose

Multiple System Atrophy

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Multimodal intervention
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Multiple System Atrophy focused on measuring Multiple System Atrophy, Quality of life, Multimodal intervention, Neurodegenerative disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Patients Inclusion Criteria :

  • Patients suffering from "possible" or "probable" MSA according to clinical consensus criteria
  • Living at home
  • Presence of at least one close person (family caregiver or not) in the entourage
  • Unified Multiple System Atrophy Rating Scale (UMSARS) IV ≤4
  • Written informed consent
  • Patient covered by the national health system

Caregivers Inclusion Criteria :

  • Age > 18
  • Able to answer to study scales and survey
  • Written informed consent

Patients Exclusion Criteria:

  • Unified Multiple System Atrophy Rating Scale (UMSARS) IV > 4
  • Absence of at least one close person

Caregivers Inclusion Criteria :

- Enable to answer to study scales and survey

Sites / Locations

  • CHU BordeauxRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Multimodal intervention at inclusion

Multimodal intervention at 6 month

Arm Description

Multimodal intervention will be proposed to Multiple system atrophy patients and their caregivers.

Multimodal intervention will be proposed to Multiple system atrophy patients and their caregivers.

Outcomes

Primary Outcome Measures

Multiple System Atrophy Quality of Life (MSA-QoL) Score
Score of emotional and social sub-dimension of the MSA Quality of Life scale. Quality of life questionnaire to collect the level of difficulty experienced by the patient (from no problem to extreme problem) during the 4 weeks preceding the interview on activities such as: moving; walking; maintaining balance; speak; feed oneself. It also assesses the patient's feelings about his illness.
Multiple System Atrophy Quality of Life (MSA-QoL) Score
Score of emotional and social sub-dimension of the MSA Quality of Life scale. Quality of life questionnaire to collect the level of difficulty experienced by the patient (from no problem to extreme problem) during the 4 weeks preceding the interview on activities such as: moving; walking; maintaining balance; speak; feed oneself. It also assesses the patient's feelings about his illness.
Multiple System Atrophy Quality of Life (MSA-QoL) Score
Score of emotional and social sub-dimension of the MSA Quality of Life scale. Quality of life questionnaire to collect the level of difficulty experienced by the patient (from no problem to extreme problem) during the 4 weeks preceding the interview on activities such as: moving; walking; maintaining balance; speak; feed oneself. It also assesses the patient's feelings about his illness.

Secondary Outcome Measures

Center for Epidemiologic Sutdies-Depression (CESD) Score
20 items scale used to assess the existence of a depressive syndrome. Scores less than 15 does not indicate any depressive disorder Scores between 15 and 21 are indicative of mild to moderate depression. Scores above 21 are consistent with the existence of severe/ major depression
Center for Epidemiologic Sutdies-Depression (CESD) Score
20 items scale used to assess the existence of a depressive syndrome. Scores less than 15 does not indicate any depressive disorder Scores between 15 and 21 are indicative of mild to moderate depression. Scores above 21 are consistent with the existence of severe/ major depression
Center for Epidemiologic Sutdies-Depression (CESD) Score
20 items scale used to assess the existence of a depressive syndrome. Scores less than 15 does not indicate any depressive disorder Scores between 15 and 21 are indicative of mild to moderate depression. Scores above 21 are consistent with the existence of severe/ major depression
Multiple System Atrophy Quality of Life (MSA-QoL) Score
Score of other sub-dimension of the MSA Quality of Life scale. The MSA-QoL questionnaire is composed of three different subscales: motor (14 items), non-motor (12 items) and emotional/social (14 items). The response options for each question range from 0 (no problem) to 4 (extreme problem) with higher total scores reflecting more impaired quality of life. The MSA-QoL also includes a visual analogue scale (VAS) of how satisfied patients feel (range 0-100, with lower scores indicating lower quality of life).
Multiple System Atrophy Quality of Life (MSA-QoL) Score
Score of other sub-dimension of the MSA Quality of Life scale. The MSA-QoL questionnaire is composed of three different subscales: motor (14 items), non-motor (12 items) and emotional/social (14 items). The response options for each question range from 0 (no problem) to 4 (extreme problem) with higher total scores reflecting more impaired quality of life. The MSA-QoL also includes a visual analogue scale (VAS) of how satisfied patients feel (range 0-100, with lower scores indicating lower quality of life).
Multiple System Atrophy Quality of Life (MSA-QoL) Score
Score of other sub-dimension of the MSA Quality of Life scale. The MSA-QoL questionnaire is composed of three different subscales: motor (14 items), non-motor (12 items) and emotional/social (14 items). The response options for each question range from 0 (no problem) to 4 (extreme problem) with higher total scores reflecting more impaired quality of life. The MSA-QoL also includes a visual analogue scale (VAS) of how satisfied patients feel (range 0-100, with lower scores indicating lower quality of life).
State Trait Inventory Anxiety (STAI) Score
Anxiety assessment. 2 scales of 20 questions used to assess how subjects feel at the time and generally. Score > 65 means high anxiety ; Score < 35 means low anxiety
State Trait Inventory Anxiety (STAI) Score
Anxiety assessment. 2 scales of 20 questions used to assess how subjects feel at the time and generally. Score > 65 means high anxiety ; Score < 35 means low anxiety
State Trait Inventory Anxiety (STAI) Score
Anxiety assessment. 2 scales of 20 questions used to assess how subjects feel at the time and generally. Score > 65 means high anxiety ; Score < 35 means low anxiety
Unified Multiple System Atrophy Rating Scale (UMSARS) I
(0=no disorder, 48=severe disorders): Is an assessment of daily life activities via 12 12 items scale used to assess language, writing, autonomy , walking and the presence of possible urinary, sexual or intestinal disorders. (0=no disorder, 48=severe)
Unified Multiple System Atrophy Rating Scale (UMSARS) I
(0=no disorder, 48=severe disorders): Is an assessment of daily life activities via 12 12 items scale used to assess language, writing, autonomy , walking and the presence of possible urinary, sexual or intestinal disorders. (0=no disorder, 48=severe)
Unified Multiple System Atrophy Rating Scale (UMSARS) I
(0=no disorder, 48=severe disorders): Is an assessment of daily life activities via 12 12 items scale used to assess language, writing, autonomy , walking and the presence of possible urinary, sexual or intestinal disorders. (0=no disorder, 48=severe)
Unified Multiple System Atrophy Rating Scale (UMSARS) II
Motor examination based on 14 items that allow to evaluate in particular facial expression, oculomotricity, oral expression, tremors or walking. 0=no disorder, 56=severe disorders
Unified Multiple System Atrophy Rating Scale (UMSARS) II
Motor examination based on 14 items that allow to evaluate in particular facial expression, oculomotricity, oral expression, tremors or walking. 0=no disorder, 56=severe disorders
Unified Multiple System Atrophy Rating Scale (UMSARS) II
Motor examination based on 14 items that allow to evaluate in particular facial expression, oculomotricity, oral expression, tremors or walking. 0=no disorder, 56=severe disorders
Unified Multiple System Atrophy Rating Scale (UMSARS) III
Blood pressure and heart rate measurements in the lying and standing position for 10 min every minute.
Unified Multiple System Atrophy Rating Scale (UMSARS) III
Blood pressure and heart rate measurements in the lying and standing position for 10 min every minute.
Unified Multiple System Atrophy Rating Scale (UMSARS) III
Blood pressure and heart rate measurements in the lying and standing position for 10 min every minute.
Unified Multiple System Atrophy Rating Scale (UMSARS) IV
Assessment of the disability from 1 to 5. 1 = completely independent ; 5 = totally dependent
Unified Multiple System Atrophy Rating Scale (UMSARS) IV
Assessment of the disability from 1 to 5. 1 = completely independent ; 5 = totally dependent
Unified Multiple System Atrophy Rating Scale (UMSARS) IV
Assessment of the disability from 1 to 5. 1 = completely independent ; 5 = totally dependent
Montreal Cognitive Assessment (MoCA) Score
evaluates short-term memory, visuospatial skills, executive functions, attention, concentration, work memory, language, abstraction, computation, and time and space orientation. Cognitive impairment is assessed by the score on 30 points (27-30: no cognitive impairment; 21-26: mild).
Montreal Cognitive Assessment (MoCA) Score
evaluates short-term memory, visuospatial skills, executive functions, attention, concentration, work memory, language, abstraction, computation, and time and space orientation. Cognitive impairment is assessed by the score on 30 points (27-30: no cognitive impairment; 21-26: mild).
Montreal Cognitive Assessment (MoCA) Score
evaluates short-term memory, visuospatial skills, executive functions, attention, concentration, work memory, language, abstraction, computation, and time and space orientation. Cognitive impairment is assessed by the score on 30 points (27-30: no cognitive impairment; 21-26: mild).
Zarit Scale score
Assesses caregiver burden. 22 item scale with total score ranging from 0 to 88. Score 20 mean zero load - Score > 60 means severe load
Zarit Scale score
Assesses caregiver burden. 22 item scale with total score ranging from 0 to 88. Score 20 mean zero load - Score > 60 means severe load
Zarit Scale score
Assesses caregiver burden. 22 item scale with total score ranging from 0 to 88. Score 20 mean zero load - Score > 60 means severe load
Family Relations Index (FRI)
27 items used to assess family functioning : family cohesion, verbalization of feelings and family conflict.
Family Relations Index (FRI)
27 items used to assess family functioning : family cohesion, verbalization of feelings and family conflict.
Family Relations Index (FRI)
27 items used to assess family functioning : family cohesion, verbalization of feelings and family conflict.

Full Information

First Posted
May 6, 2021
Last Updated
August 4, 2021
Sponsor
University Hospital, Bordeaux
search

1. Study Identification

Unique Protocol Identification Number
NCT04965922
Brief Title
Quality of Life of Caregivers and Patients Suffering From Multiple System Atrophy
Acronym
QUA2-AMS
Official Title
Quality of Life of Caregivers and Patients Suffering From Multiple System Atrophy
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
July 1, 2021 (Actual)
Primary Completion Date
July 1, 2022 (Anticipated)
Study Completion Date
July 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Bordeaux

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Multiple system atrophy (MSA) is a rare and fatal neurodegenerative disorder that cause as other neurodegenerative diseases profound declines in functioning and thus, require caregiving for assistance with daily living. The aim of the study is to evaluate the effect of a multimodal intervention as proposed by the NYU Caregiver Counseling and Support Intervention (NYUCI) on the quality of life of patients and their caregivers.
Detailed Description
Multiple system atrophy (MSA) is a rare and fatal neurodegenerative disorder, which is characterized by a variable combination of parkinsonism, cerebellar dysfunction, autonomic failure, and additional signs. No effective treatment is available. MSA patients have a poor prognosis with a median survival ranging between 6 and 10 years. MSA as other neurodegenerative diseases cause profound declines in functioning ; thus, many patients require caregivers for assistance with daily living. Caregiving can also be extremely stressful, and many caregivers experience declines in mental health. All of these repercussions contribute to the deterioration of the caregiver's quality of life and they can have an impact on the patient, in particular, on the patient's survival. Improving quality of life is a major element and identifying effective targeted interventions would bring immediate and direct benefit to patients and their families. In this context, it seems that a multimodal intervention as proposed by the NYU Caregiver Counseling and Support Intervention (NYUCI) developed by Mittelman could contribute to improve disease management and better coping with daily living difficulties. The NYUCI strategy combines sessions of individual and family counseling, support group participation, and additional on-call telephone consultations in a flexible counseling approach that is tailored to each caregiving family

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple System Atrophy
Keywords
Multiple System Atrophy, Quality of life, Multimodal intervention, Neurodegenerative disease

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
144 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Multimodal intervention at inclusion
Arm Type
Experimental
Arm Description
Multimodal intervention will be proposed to Multiple system atrophy patients and their caregivers.
Arm Title
Multimodal intervention at 6 month
Arm Type
Other
Arm Description
Multimodal intervention will be proposed to Multiple system atrophy patients and their caregivers.
Intervention Type
Behavioral
Intervention Name(s)
Multimodal intervention
Intervention Description
The intervention consists of identifying the individual needs of each caregiver and patient and identifying sources of improvement in the management of daily life, including the optimization of social support. This optimization requires the involvement of people in the environment (family, friends, neighbours) who can provide help, support of any kind, recurrent or punctual, minimizing negative family interactions and maximizing positive contributions by each in supporting and supporting the individual. The intervention is personalized in the sense that the content of each session seeks to adapt itself to the specificities of the couple situation and its surroundings. interviews/meetings involving a psychologist social worker.
Primary Outcome Measure Information:
Title
Multiple System Atrophy Quality of Life (MSA-QoL) Score
Description
Score of emotional and social sub-dimension of the MSA Quality of Life scale. Quality of life questionnaire to collect the level of difficulty experienced by the patient (from no problem to extreme problem) during the 4 weeks preceding the interview on activities such as: moving; walking; maintaining balance; speak; feed oneself. It also assesses the patient's feelings about his illness.
Time Frame
Day 0
Title
Multiple System Atrophy Quality of Life (MSA-QoL) Score
Description
Score of emotional and social sub-dimension of the MSA Quality of Life scale. Quality of life questionnaire to collect the level of difficulty experienced by the patient (from no problem to extreme problem) during the 4 weeks preceding the interview on activities such as: moving; walking; maintaining balance; speak; feed oneself. It also assesses the patient's feelings about his illness.
Time Frame
6 month
Title
Multiple System Atrophy Quality of Life (MSA-QoL) Score
Description
Score of emotional and social sub-dimension of the MSA Quality of Life scale. Quality of life questionnaire to collect the level of difficulty experienced by the patient (from no problem to extreme problem) during the 4 weeks preceding the interview on activities such as: moving; walking; maintaining balance; speak; feed oneself. It also assesses the patient's feelings about his illness.
Time Frame
12 month
Secondary Outcome Measure Information:
Title
Center for Epidemiologic Sutdies-Depression (CESD) Score
Description
20 items scale used to assess the existence of a depressive syndrome. Scores less than 15 does not indicate any depressive disorder Scores between 15 and 21 are indicative of mild to moderate depression. Scores above 21 are consistent with the existence of severe/ major depression
Time Frame
Day 0
Title
Center for Epidemiologic Sutdies-Depression (CESD) Score
Description
20 items scale used to assess the existence of a depressive syndrome. Scores less than 15 does not indicate any depressive disorder Scores between 15 and 21 are indicative of mild to moderate depression. Scores above 21 are consistent with the existence of severe/ major depression
Time Frame
3 month
Title
Center for Epidemiologic Sutdies-Depression (CESD) Score
Description
20 items scale used to assess the existence of a depressive syndrome. Scores less than 15 does not indicate any depressive disorder Scores between 15 and 21 are indicative of mild to moderate depression. Scores above 21 are consistent with the existence of severe/ major depression
Time Frame
6 month
Title
Multiple System Atrophy Quality of Life (MSA-QoL) Score
Description
Score of other sub-dimension of the MSA Quality of Life scale. The MSA-QoL questionnaire is composed of three different subscales: motor (14 items), non-motor (12 items) and emotional/social (14 items). The response options for each question range from 0 (no problem) to 4 (extreme problem) with higher total scores reflecting more impaired quality of life. The MSA-QoL also includes a visual analogue scale (VAS) of how satisfied patients feel (range 0-100, with lower scores indicating lower quality of life).
Time Frame
Day 0
Title
Multiple System Atrophy Quality of Life (MSA-QoL) Score
Description
Score of other sub-dimension of the MSA Quality of Life scale. The MSA-QoL questionnaire is composed of three different subscales: motor (14 items), non-motor (12 items) and emotional/social (14 items). The response options for each question range from 0 (no problem) to 4 (extreme problem) with higher total scores reflecting more impaired quality of life. The MSA-QoL also includes a visual analogue scale (VAS) of how satisfied patients feel (range 0-100, with lower scores indicating lower quality of life).
Time Frame
3 month
Title
Multiple System Atrophy Quality of Life (MSA-QoL) Score
Description
Score of other sub-dimension of the MSA Quality of Life scale. The MSA-QoL questionnaire is composed of three different subscales: motor (14 items), non-motor (12 items) and emotional/social (14 items). The response options for each question range from 0 (no problem) to 4 (extreme problem) with higher total scores reflecting more impaired quality of life. The MSA-QoL also includes a visual analogue scale (VAS) of how satisfied patients feel (range 0-100, with lower scores indicating lower quality of life).
Time Frame
6 month
Title
State Trait Inventory Anxiety (STAI) Score
Description
Anxiety assessment. 2 scales of 20 questions used to assess how subjects feel at the time and generally. Score > 65 means high anxiety ; Score < 35 means low anxiety
Time Frame
Day 0
Title
State Trait Inventory Anxiety (STAI) Score
Description
Anxiety assessment. 2 scales of 20 questions used to assess how subjects feel at the time and generally. Score > 65 means high anxiety ; Score < 35 means low anxiety
Time Frame
3 month
Title
State Trait Inventory Anxiety (STAI) Score
Description
Anxiety assessment. 2 scales of 20 questions used to assess how subjects feel at the time and generally. Score > 65 means high anxiety ; Score < 35 means low anxiety
Time Frame
6 month
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) I
Description
(0=no disorder, 48=severe disorders): Is an assessment of daily life activities via 12 12 items scale used to assess language, writing, autonomy , walking and the presence of possible urinary, sexual or intestinal disorders. (0=no disorder, 48=severe)
Time Frame
Day 0
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) I
Description
(0=no disorder, 48=severe disorders): Is an assessment of daily life activities via 12 12 items scale used to assess language, writing, autonomy , walking and the presence of possible urinary, sexual or intestinal disorders. (0=no disorder, 48=severe)
Time Frame
3 month
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) I
Description
(0=no disorder, 48=severe disorders): Is an assessment of daily life activities via 12 12 items scale used to assess language, writing, autonomy , walking and the presence of possible urinary, sexual or intestinal disorders. (0=no disorder, 48=severe)
Time Frame
6 month
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) II
Description
Motor examination based on 14 items that allow to evaluate in particular facial expression, oculomotricity, oral expression, tremors or walking. 0=no disorder, 56=severe disorders
Time Frame
Day 0
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) II
Description
Motor examination based on 14 items that allow to evaluate in particular facial expression, oculomotricity, oral expression, tremors or walking. 0=no disorder, 56=severe disorders
Time Frame
3 month
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) II
Description
Motor examination based on 14 items that allow to evaluate in particular facial expression, oculomotricity, oral expression, tremors or walking. 0=no disorder, 56=severe disorders
Time Frame
6 month
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) III
Description
Blood pressure and heart rate measurements in the lying and standing position for 10 min every minute.
Time Frame
Day 0
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) III
Description
Blood pressure and heart rate measurements in the lying and standing position for 10 min every minute.
Time Frame
3 month
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) III
Description
Blood pressure and heart rate measurements in the lying and standing position for 10 min every minute.
Time Frame
6 month
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) IV
Description
Assessment of the disability from 1 to 5. 1 = completely independent ; 5 = totally dependent
Time Frame
Day 0
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) IV
Description
Assessment of the disability from 1 to 5. 1 = completely independent ; 5 = totally dependent
Time Frame
3 month
Title
Unified Multiple System Atrophy Rating Scale (UMSARS) IV
Description
Assessment of the disability from 1 to 5. 1 = completely independent ; 5 = totally dependent
Time Frame
6 month
Title
Montreal Cognitive Assessment (MoCA) Score
Description
evaluates short-term memory, visuospatial skills, executive functions, attention, concentration, work memory, language, abstraction, computation, and time and space orientation. Cognitive impairment is assessed by the score on 30 points (27-30: no cognitive impairment; 21-26: mild).
Time Frame
Day 0
Title
Montreal Cognitive Assessment (MoCA) Score
Description
evaluates short-term memory, visuospatial skills, executive functions, attention, concentration, work memory, language, abstraction, computation, and time and space orientation. Cognitive impairment is assessed by the score on 30 points (27-30: no cognitive impairment; 21-26: mild).
Time Frame
3 month
Title
Montreal Cognitive Assessment (MoCA) Score
Description
evaluates short-term memory, visuospatial skills, executive functions, attention, concentration, work memory, language, abstraction, computation, and time and space orientation. Cognitive impairment is assessed by the score on 30 points (27-30: no cognitive impairment; 21-26: mild).
Time Frame
6 month
Title
Zarit Scale score
Description
Assesses caregiver burden. 22 item scale with total score ranging from 0 to 88. Score 20 mean zero load - Score > 60 means severe load
Time Frame
Day 0
Title
Zarit Scale score
Description
Assesses caregiver burden. 22 item scale with total score ranging from 0 to 88. Score 20 mean zero load - Score > 60 means severe load
Time Frame
3 month
Title
Zarit Scale score
Description
Assesses caregiver burden. 22 item scale with total score ranging from 0 to 88. Score 20 mean zero load - Score > 60 means severe load
Time Frame
6 month
Title
Family Relations Index (FRI)
Description
27 items used to assess family functioning : family cohesion, verbalization of feelings and family conflict.
Time Frame
Day 0
Title
Family Relations Index (FRI)
Description
27 items used to assess family functioning : family cohesion, verbalization of feelings and family conflict.
Time Frame
3 month
Title
Family Relations Index (FRI)
Description
27 items used to assess family functioning : family cohesion, verbalization of feelings and family conflict.
Time Frame
6 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Patients Inclusion Criteria : Patients suffering from "possible" or "probable" MSA according to clinical consensus criteria Living at home Presence of at least one close person (family caregiver or not) in the entourage Unified Multiple System Atrophy Rating Scale (UMSARS) IV ≤4 Written informed consent Patient covered by the national health system Caregivers Inclusion Criteria : Age > 18 Able to answer to study scales and survey Written informed consent Patients Exclusion Criteria: Unified Multiple System Atrophy Rating Scale (UMSARS) IV > 4 Absence of at least one close person Caregivers Inclusion Criteria : - Enable to answer to study scales and survey
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alexandra FOUBERT-SAMIER
Phone
05 57 82 14 20
Email
alexandra.samier-foubert@u-bordeaux.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Valérie BERGUA
Phone
05 57 57 30 27
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alexandra FOUBERT-SAMIER
Organizational Affiliation
University Hospital, Bordeaux
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Bordeaux
City
Bordeaux
ZIP/Postal Code
33 076
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alexandra FOUBERT-SAMIER, Dr
Phone
05 57 82 14 20
Email
alexandra.samier-foubert@u-bordeaux.fr
First Name & Middle Initial & Last Name & Degree
Sandrine VILLARS
Phone
05 57 82 12 59
Email
sandrine.villars@chu-bordeaux.fr

12. IPD Sharing Statement

Learn more about this trial

Quality of Life of Caregivers and Patients Suffering From Multiple System Atrophy

We'll reach out to this number within 24 hrs